Search
for
Sort by
Research 241–270 of 1000+
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- An adolescent girl with coexisting ovarian mature cystic teratoma and HAIR-AN syndrome, an extreme subtype of polycystic ovarian syndrome
- Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
- Assessment of cardiovascular risk in patients with androgenetic alopecia using high-sensitivity C-reactive protein and lipoprotein a
- Ovarian intratumoral 21-hydroxylase deficiency in a postmenopausal hirsute woman
- An Occult Leydig Cell Tumour in a Postmenopausal Woman Presenting with Alopecia and Hirsutism: A Case Report
- The Role of Probiotics and Synbiotics on Hirsutism
- A benign cause of hyperandrogenism in a postmenopausal woman
- Inflammatory and Anti-Inflammatory Parameters in PCOS Patients Depending on Body Mass Index: A Case-Control Study
- Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations
- Androgen insufficiency in women: diagnostic and therapeutic implications
- Neuroendocrine Determinants of Polycystic Ovary Syndrome
- Selective Pituitary Resistance to Thyroid Hormone: Clinical Hyperthyroidism with High TSH on Levothyroxine Administration in I-131 Ablated “Graves Disease”
- Concurrent autoimmune and endocrine dysregulation in polycystic ovary syndrome
- Finasteride Alleviates High Fat Associated Protein-Overload Nephropathy by Inhibiting Trimethylamine N-Oxide Synthesis and Regulating Gut Microbiota
- In Search of New Therapeutics—Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond
- Efficacy of bergamot: From anti‐inflammatory and anti‐oxidative mechanisms to clinical applications as preventive agent for cardiovascular morbidity, skin diseases, and mood alterations
- Inflammatory perspectives of polycystic ovary syndrome: role of specific mediators and markers
- Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons
- The Role of 11-Oxygenated Androgens and Endocrine Disruptors in Androgen Excess Disorders in Women
- Does an apple a day keep away diseases? Evidence and mechanism of action
- The Current and Emerging Role of Statins in the Treatment of PCOS: The Evidence to Date
- An N-Ethyl-N-Nitrosourea Induced Corticotropin-Releasing Hormone Promoter Mutation Provides a Mouse Model for Endogenous Glucocorticoid Excess
- Correlation of Hair Mineral Concentrations with Insulin Resistance in Korean Males
- Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia
- The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study
- Chemokine C-C Motif Ligand 7 (CCL7), a Biomarker of Atherosclerosis, Is Associated with the Severity of Alopecia Areata: A Preliminary Study
- Insulin Resistance, Metabolic Syndrome, and Inflammatory Skin Disease
- Polycystic Ovary Syndrome and Eating Disorders—A Literature Review
- Loss of ERBB2 and ERBB3 Receptors Impacts Epidermal Differentiation in Mice